Clinical Trial

Alcohol, Cannabis, and Driving Substudy III

Study Description

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Active Dronabinol

10 mg capsule of Dronabinol will be administered orally.

Drug - Placebo

Control: no alcohol, administered for ~80 minutes.

Drug - Placebo

Control: Placebo pill (no active cannabinoids) administered orally.

Drug - Active Ethanol

Target BrAC of 0.04% reached over 20 minutes and then clamped to maintain this dose for an additional 60 minutes. This dose is equivalent to consuming approximately 2 drinks over 1 hour. Administered over a total of 80 minutes.

Additional Information

Official Study Title

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

Clinical Trial ID

NCT02710331

ParticipAid ID

ZdPJ6a